Membranous nephropathy: systems biology-based novel mechanism and traditional Chinese medicine therapy

H Miao, Y Zhang, X Yu, L Zou, Y Zhao - Frontiers in pharmacology, 2022 - frontiersin.org
Membranous nephropathy (MN) is a renal-limited non-inflammatory autoimmune disease in
the glomerulus, which is the second or third main cause of end-stage kidney diseases in …

Membranous nephropathy: mechanistic insights and therapeutic perspectives

MR Hua, YL Zhao, JZ Yang, L Zou, YY Zhao… - International …, 2023 - Elsevier
Membranous nephropathy (MN) is one of the most common causes of non-diabetic
nephrotic syndrome in adults. About 80% of cases are renal limited (primary MN) and 20 …

Recent advances in clinical diagnosis and pharmacotherapy options of membranous nephropathy

YN Wang, HY Feng, X Nie, YM Zhang, L Zou… - Frontiers in …, 2022 - frontiersin.org
Membranous nephropathy (MN) is the most common cause of nephrotic syndrome among
adults, which is the leading glomerular disease that recurs after kidney transplantation …

Single-cell profiling reveals transcriptional signatures and cell-cell crosstalk in anti-PLA2R positive idiopathic membranous nephropathy patients

J Xu, C Shen, W Lin, T Meng, JD Ooi… - Frontiers in …, 2021 - frontiersin.org
Idiopathic membranous nephropathy (IMN) is an organ-specific autoimmune disease of the
kidney glomerulus. It may gradually progress to end-stage renal disease (ESRD) …

Ferroptosis is involved in passive Heymann nephritis in rats

X Shi, Q Zhang, M Chang, Y Zhang, MM Zhao, B Yang… - Heliyon, 2023 - cell.com
Ferroptosis is found to be involved in some experimental models of kidney diseases, but its
role in membrane nephropathy (MN) is still unclear. The purpose of this study is to explore …

From KDIGO 2012 towards KDIGO 2021 in idiopathic membranous nephropathy guidelines: what has changed over the last 10 years?

S Stai, G Lioulios, M Christodoulou, A Papagianni… - Journal of …, 2023 - Springer
The recommendations in the Kidney Disease: Improving Global Outcomes (KDIGO) 2021
guidelines regarding Idiopathic Membranous Nephropathy (IMN) management include …

Glomerulus-Targeted ROS-Responsive Polymeric Nanoparticles for Effective Membranous Nephropathy Therapy

L Guo, H Yan, Q Gong, W Zheng, L Zhong… - … Applied Materials & …, 2024 - ACS Publications
Membranous nephropathy (MN) is a common immune-mediated glomerular disease that
requires the development of safe and highly effective therapies. Celastrol (CLT) has shown …

Idiopathic membranous nephropathy with renal amyloidosis: a case report

Y Wang, X Wang, J Yu, S Wu, Z Xu, W Sun - Frontiers in Medicine, 2022 - frontiersin.org
Background Immunoglobulin light chain amyloidosis is a clonal, non-proliferative plasma
cell disorder, in which fragments of immunoglobulin light chain are deposited in tissues …

Macrophage migration inhibitory factor levels are associated with disease activity and possible complications in membranous nephropathy

N Ding, PL Li, KL Wu, TG Lv, WL Yu, J Hao - Scientific Reports, 2022 - nature.com
Membranous nephropathy (MN) is an autoimmune disease characterized by the deposition
of immunoglobulin G (IgG) and complementary components in the epithelium of the …

MicroRNAs in childhood nephrotic syndrome

MC Dhandapani, V Venkatesan… - Journal of Cellular …, 2021 - Wiley Online Library
The discovery of microRNAs (miRNAs) has opened up new avenues of research to
understand the molecular basis of a number of diseases. Because of their conservative …